Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis.
Diagnostic markers of axonal degeneration and demyelination in sensory nerve conduction.
Thalamus pathology in multiple sclerosis: from biology to clinical application.
Aerobic exercise in people with multiple sclerosis: its feasibility and secondary benefits.
Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis - insights into possible drug mechanism.
Late-onset multiple sclerosis in South-East wales.
Perceived Cognitive Difficulties and Cognitive Test Performance as Predictors of Employment Outcomes in People with Multiple Sclerosis.
Validation of the Serbian Version of Multiple Sclerosis Spasticity Scale 88 (MSSS-88).
Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats.
Perception of Pain Self-efficacy and Fatigue in Greek Patients with Multiple Sclerosis: A Study Protocol.
The Use of MiRNA Antagonists in the Alleviation of Inflammatory Disorders.
Global and 3D Spatial Assessment of Neuroinflammation in Rodent Models of Multiple Sclerosis.
Lipid Resonance on In Vivo Proton MR Spectroscopy: Value of Other Metabolites in Differential Diagnosis.
Recurrent Guillain-Barré syndrome presenting stereotypic manifestations, positive antiganglioside antibodies, and rapid recovery.
Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis.
Detection of clinical relapses in multiple sclerosis cohorts: construction and validation of a model based on administrative data.
Endocannabinoid signalling and the deteriorating brain.
Neurodegeneration Triggers Peripheral Immune Cell Recruitment into the Forebrain.
Differential effects of genetic susceptibility factors in males and females with multiple sclerosis.
The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis?
Potential For Cell-mediated Immune Responses In Mouse Models Of Pelizaeus-Merzbacher Disease.
[Reflections on the outcome measures in the clinical trials of multiple sclerosis].
[Foix-Chavany-Marie syndrome presenting as multiple sclerosis].
Epigenetic regulation of polyomavirus JC involves acetylation of specific lysine residues in NF-κB p65.
IV immunoglobulin confounds JC virus antibody serostatus determination.
Pages
« first
‹ previous
…
556
557
558
559
560
561
562
563
564
…
next ›
last »